profit from every €100 of sales.
€0€100
Aedifica NV/SA
€65.60+0.08% today
-1.8% since Dec 19, 25
1-year low €60.551-year high €79.25
Trading in the middle of its range for the past year.
The essentials
Four questions every investor asks, answered in one line each.
more sales each year, on average, 2022 to 2025.
0%20% a year
You pay €22.40 for every €1 of profit it makes in a year.
CheapExpensive
of earnings would pay off all its debt.
No debt5 years
Money in, money out
What Aedifica NV/SA sold, what it kept, and what it did with the cash.
Sales went from €277 million in 2022 to €370 million in 2025, with €244 million of profit last year.
SalesProfit
Aedifica NV/SA handed back 84% of the cash it generated last year.
€186M
Free cash flow 2025€220M
Bought back its own shares–
Paid as dividends€186M
Cash vs. debt€22M vs. €2.6B
Aedifica NV/SA vs. similar companies
Aedifica NV/SA grows in the middle of these 5 and is the cheapest for its profits.
| Company | Profit from €100 of sales | Sales growth a year | Price per €1 of profit |
|---|---|---|---|
| Aedifica NV/SA | 22.4× · Fair price | ||
 Welltower | 193.9× · Very expensive | ||
 Ventas | 190.0× · Very expensive | ||
 Omega Healthcare Investors | 26.3× · Fair price | ||
 Healthpeak Properties | 207.7× · Very expensive |
AI analysis
An AI analyst reads Aedifica NV/SA's last five years, its segments, earnings, insiders and peers, and writes the bull case, the bear case and what the price expects.
Run the AI analysisFull statementsIncome, balance sheet and cash flow, year by year
Income statement
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 277 | 321 | 348 | 370 | |
| 263 | 302 | 326 | 349 | |
| 230 | 266 | 290 | 312 | |
| 415 | 73 | 292 | 354 | |
| 332 | 25 | 205 | 244 | |
| 8.51 | 0.56 | 4.31 | 5.14 | |
| 94.8% | 93.9% | 93.8% | 94.2% | |
| 82.9% | 82.7% | 83.5% | 84.3% | |
| 119.7% | 7.6% | 58.9% | 66.0% |
Balance sheet
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 6,086 | 6,177 | 6,464 | 6,477 |
| Cash | 14 | 18 | 18 | 22 |
| Total debt | 2,528 | 2,358 | 2,595 | 2,570 |
| Total liabilities | 2,796 | 2,596 | 2,816 | 2,808 |
| 3,283 | 3,576 | 3,643 | 3,664 | |
| 39 | 44 | 48 | 48 | |
| 5.6% | 0.9% | 3.7% | 4.4% | |
| 10.1% | 0.7% | 5.6% | 6.7% |
Cash flow
| In millions of EUR | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| 219 | 230 | 248 | 318 | |
| 310 | 261 | 144 | 97 | |
| -91 | -31 | 105 | 220 | |
| Dividends paid | 119 | 116 | 167 | 186 |
| – | – | – | – | |
| – | – | – | – |
Valuation
- 22.4×
- –
- –
- 1.6×
- 14.8×
- 24.8×
- 22.7×
- 4.0%
- 4.5%
- 3.4%
Profitability
- 94.2%
- 84.3%
- 66.0%
- –
- 4.2%
- 3.5%
- –
- –
- –
- –
Growth
- +10.1%
- −15.5%
- –
- –
- +6.8%
Financial health
- 7.2×
- 0.70
- –
- 5.2×
- 0.22
- –
- –
How it ranks in Real Estate
Each dot is where the company stands among every company over $300M in the sector. Further right is better.
Bottom 46%of 746
Top 2%of 752
Bottom 34%of 666
Top 38%of 762
Bottom 38%of 763
3.4%of the share price, paid each year
On $1,000 invested$34a year at today's yield, before tax
–per share
Raised–not every year
How safe it looks
75.9% of its profit
Room to growStretchedMore than it earns: 84.2%
News
No recent news on file.
Insider trades
Our insider feed has not updated since May 26, 2026. Trades filed after that are not listed yet.
No insider trades on file.
Not enough data
Questions about Aedifica NV/SA
Is Aedifica NV/SA a good stock to buy?
A business with weak numbers at a fair price. Whether it suits you depends on your goals and the price you pay; invest-like never tells anyone to buy or sell. The AI analysis lays out the case for and against. Read the Aedifica NV/SA AI analysis
What does Aedifica NV/SA do?
Aedifica NV/SA is a Belgian public regulated real estate company specializing in European healthcare real estate, particularly properties for elderly care. It is in REIT - Healthcare Facilities, based in Brussels, Belgium, with 127 employees.
Does Aedifica NV/SA pay a dividend?
Yes. At today's price the dividend is 3.4% a year, about 76% of its yearly profit. In 2025 it paid out €186 million in dividends.
Is Aedifica NV/SA stock halal?
No. Aedifica NV/SA does not pass our halal screen: its debt is 47% of its market value, at or above the 33% limit. How we check
Who are Aedifica NV/SA's competitors?
The largest listed companies in the same industry are Welltower, Ventas, Omega Healthcare Investors and Healthpeak Properties. The peers table on this page compares their profit, growth and price with Aedifica NV/SA's.
Prices: daily closes to Nov 10, 2026. Fundamentals: company reports via invest-like data.